HOTH News and Press, Hoth Therapeutics Inc. From 02/25/21

Hoth Therapeutics Retains RedChip to Increase Investor Awareness PR Newswire NEW YORK , Feb. 25, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced it retained RedChip Companies, Inc. ("RedChip...

Hoth Therapeutics ([[HOTH]] +16.2%) has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer's disease.The company has also secured an exclusive lic...

Hoth Therapeutics Expands Intellectual Property Portfolio with Novel Alzheimer's Treatment PR Newswire NEW YORK , Feb. 24, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has filed a p...

Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of HT-001 For Cancer Patients Hoth intends to pursue FDA Expedited Programs, such as Breakthrough Designation, pending generation of future clinical study data for HT-001...

Hoth Therapeutics (HOTH) intends to expand the development of the HT-003 active pharmaceutical ingredient ((API)) to pursue a new indication for the treatment of inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis.Hoth executed an option agreement with Is...

Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS) +35%.Cleveland BioLabs (CB...

Hoth Therapeutics' HT-003 Shows Anti-inflammatory Benefits, Hoth to Expand Drug Development to Include Treatment of Inflammatory Bowel Diseases (IBDs) HT-003 API will be investigated for potential therapeutic action for treatment of IBDs PR Newswire NEW YORK , ...

Hoth Therapeutics Scientific Advisory Board Member, Michael Peters, Ph.D., Publishes Whitepaper Regarding COVID-19 SARS-CoV-2 in bioRxiv Whitepaper is titled, "Transformations, Comparisons, Analysis of Down to Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Prot...

NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today it has initiated its second set of preclinical animal testing of its HaloVax™ Self-Assembling Vaccine (SAV) against COVID-19. This study will investigate an updated construct, based on initial ...

Hoth Therapeutics ([[HOTH]] +9.6%) has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application for its HT-001 topical product to the U.S. FDA for initiating the first clinical trial.The company will write, p...